Zinc finger factor 521 enhances adipogenic differentiation of mouse multipotent cells and human bone marrow mesenchymal stem cells

Oncotarget

Volumn 6, Issue 17, 2015, Pages 14874-14884

  Tseng, Kuo Yun ^a   Lin, Shankung ^a,b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adipogenesis; Age related bone loss; Aging; Marrow MSC; Osteoporosis

Indexed keywords

DNA BINDING PROTEIN; EVI3 PROTEIN, MOUSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BINDING; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN 521, HUMAN;

ADIPOCYTE; ADIPOGENESIS; ANIMAL; BONE DEVELOPMENT; C3H MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION; GENETICS; HEK293 CELL LINE; HUMAN; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; MULTIPOTENT STEM CELL; OSTEOBLAST; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION; HEK293 CELLS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE, INBRED C3H; MIDDLE AGED; MULTIPOTENT STEM CELLS; OSTEOBLASTS; OSTEOGENESIS; PPAR GAMMA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

EID: 84934279072     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3900     Document Type: Article

References (20)

1. Demontiero O, Vidal C, Duque G. Aging and bone loss: new insights for the clinician. Ther. Adv. Musculoskel. Dis. 2012; 4:61-76.
2. Verma S, Rajaratnam J, Denton J, Hoyland J, Byers R. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J. Clin. Pathol. 2002; 55:693-698.
3. Rosen C, Bouxsien M. Mechanisms of disease: Is osteoporosis the obesity of bone?. Nat. Clin. Pract. Rheumatol. 2006; 2:35-43.
4. Duque G, Rivas D, Li W, Li A, Henderson J, Ferland G, Gaudreau P. Age-related bone loss in the LOU/c rat model of healthy ageing. Exp. Gerontol. 2009; 44:183-189.
5. Liang CT, Barnes J, Seedor H, Quartuccio HA, Bolander M, Jeffrey JJ, Rodan GA. Impaired bone activity in aged rats: Alterations at the cellular and molecular levels. Bone. 1992; 13:435-441.
6. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997; 89:755-764.
7. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiationand bone development. Cell. 1997; 89:765-771.
8. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994; 79:1147-1156.
9. Cornelius P, MacDougald OA, Lane MD. Regulation of adipocyte development. Annu. Rev. Nutr. 1994; 14:99-129.
10. Ren D, Collingwood TN, Rebar EJ, Wolffe AP, Camp HS. PPAR-gamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis. Genes Dev. 2002; 16:27-32.
11. Hong J-H, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, Hopkins N, Yaffe MB. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science. 2005; 309:1074-1078.
12. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marroq stroma/stem cells: the role of PPAR-?2 transcription factor and TGF-β/BMP signaling pathways. Aging Cell. 2004; 3:379-389.
13. Jiang SS, Chen C-H, Tseng K-Y, Tsai F-Y, Wang MJ, Chang I-S, Lin J-L, Lin S. Gene expression profiling suggests a pathological role of human bone marrow-derived mesenchymal stem cells in aging-related skeletal diseases. Aging-US. 2011; 3:672-684.
14. Hesse E, Kiviranta R, Wu M, Saito H, Yamana K, Correa D, Atfi A, Baron R. Zinc finger protein 521, a new player in bone formation. Ann. N.Y. Acad. Sci. 2010; 1192:32-37.
15. Kang S, Akerblad P, Kiviranta R, Gupta RK, Kajimura S, Griffin MJ, Min J, Baron R, Rosen ED. Regulation of early adipose commitment by Zfp521. PLOS Biology. 2012; 10:e1001433.
16. Lecka-Czernik B, Gubrij I, Moerman EA, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR-gamma 2. J. Cell Biochem. 1999; 74:357-371.
17. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J. Clin. Invest. 2004; 113:846-855.
18. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006; 4:263-273.
19. Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol. Metab. 2009; 20:107-114.
20. Matsubara E, Sakai I, Yamanouchi J, Fujiwara H, Yakushijin Y, Hato T, Shigemoto K, Yasukawa M. The role of zinc finger protein 521/early hematopoietic zinc finger protein in erythroid cell differentiation. J. Biol. Chem. 2009; 284:3480-3487.